Centura Pharmaceuticals
Private Company
Funding information not available
Overview
Centura Pharmaceuticals is a private, commercial-stage company focused on the OTC topical analgesic market. Its core product is a multi-agent numbing cream (Benzocaine, Lidocaine, Tetracaine) sold in single-use sachets directly to consumers, claiming to offer the strongest non-prescription strength available. The company appears to be revenue-generating with a direct-to-consumer e-commerce model, having shipped products across all 50 US states and territories. Its strategy centers on providing high-strength, convenient, OTC alternatives for minor procedural pain and itching.
Technology Platform
Formulation and packaging platform for maximum-strength OTC topical anesthetics, utilizing single-use sachets for stability and precise dosing.
Opportunities
Risk Factors
Competitive Landscape
Centura competes in the OTC topical analgesic space against large consumer health companies (e.g., Johnson & Johnson, Prestige Consumer Healthcare), generic drug manufacturers, and numerous DTC startups. Its key differentiator is the triple-agent, single-use sachet format at maximum OTC strengths, competing directly with both standard creams and pharmacy-compounded formulations.